Published

Pertussis vaccine acellular with diphtheria and tetanus toxoids (Adacel) has been approved by the PBAC for use under the National Immunisation Program (NIP). The vaccine is restricted to active immunisation in adolescents aged at least 10 years but less than 18 years, as a booster after primary immunisation.

This is the first vaccine to be considered under new arrangements in which advice on funding vaccines has become the function of the PBAC. The NIP, under which the Department of Health and Ageing provides free vaccines to Australians, will replace the Australian Standard Vaccination Schedule.